 | Up a level |
Number of items: 1.
Boyce, M, Moore, AR, Sagatun, L, Parsons, BN 
ORCID: 0000-0003-3599-1089, Varro, A, Campbell, F, Fossmark, R, Waldum, HL and Pritchard, DM
(2017)
Netazepide, a gastrin/cholecystokinin‐2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
British Journal of Clinical Pharmacology, 83 (3).
pp. 466-475.